Piotr Ponikowski Selected Research

Uric Acid (Urate)

1/2023	Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER.
10/2022	Effects of Empagliflozin in Women and Men With Heart Failure and Preserved Ejection Fraction.
1/2022	Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF.
6/2021	Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial.
5/2021	Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model.
9/2007	Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
2/2007	Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
4/2003	Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Ponikowski Research Topics

Disease

458	Heart Failure 05/2024 - 04/2003
59	Iron Deficiencies 05/2024 - 01/2008
31	Cardiomyopathies (Cardiomyopathy) 05/2024 - 02/2007
23	Atrial Fibrillation 11/2023 - 01/2012
21	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2015
21	Dyspnea (Shortness of Breath) 01/2023 - 01/2010
19	Myocardial Infarction 04/2024 - 01/2008
19	Renal Insufficiency (Renal Failure) 01/2023 - 04/2009
16	Inflammation (Inflammations) 05/2024 - 06/2006
14	Stroke (Strokes) 11/2022 - 03/2012
13	Chronic Renal Insufficiency 04/2024 - 05/2011
13	Anemia 01/2023 - 02/2007
12	Hypoxia (Hypoxemia) 01/2022 - 06/2013
12	Systolic Heart Failure 01/2021 - 01/2009
10	Heart Diseases (Heart Disease) 11/2023 - 01/2011
8	Hypertension (High Blood Pressure) 01/2023 - 08/2012
8	Disease Progression 08/2022 - 10/2010
8	Hypotension (Low Blood Pressure) 01/2022 - 11/2019
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 01/2011
8	Ischemic Stroke 10/2016 - 05/2012
7	Weight Loss (Weight Reduction) 05/2024 - 05/2013
7	Body Weight (Weight, Body) 01/2024 - 02/2007
5	Left Ventricular Dysfunction 04/2024 - 01/2008
5	Frailty 01/2024 - 01/2020
5	Tachycardia (Tachyarrhythmias) 01/2022 - 10/2013
5	Acute Coronary Syndrome 09/2021 - 01/2011
5	Central Sleep Apnea (Central Sleep Apnea Syndrome) 01/2021 - 01/2013
5	Hemorrhage 09/2015 - 05/2012
4	Hypertrophy 11/2023 - 05/2018
4	Neoplasms (Cancer) 01/2022 - 01/2011

Drug/Important Bio-Agent (IBA)

57	IronIBA 05/2024 - 01/2008
49	dapagliflozinIBA 05/2024 - 01/2019
47	Biomarkers (Surrogate Marker)IBA 05/2024 - 09/2007
39	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 11/2007
32	SodiumIBA 05/2024 - 03/2010
32	empagliflozinIBA 04/2024 - 11/2017
31	ferric carboxymaltoseIBA 01/2024 - 11/2009
26	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 09/2005
24	vericiguatIBA 03/2024 - 09/2014
22	DiureticsIBA 03/2024 - 01/2010
21	Natriuretic PeptidesIBA 10/2022 - 03/2006
19	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 09/2007
18	rolofyllineIBA 11/2019 - 01/2010
17	Ferritins (Ferritin)IBA 05/2024 - 12/2009
17	Sodium-Glucose Transport ProteinsIBA 04/2024 - 11/2019
17	Sodium-Glucose Transporter 2 InhibitorsIBA 12/2023 - 11/2017
16	Transferrin (beta 2 Transferrin)IBA 05/2024 - 12/2009
15	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 05/2012
15	Warfarin (Coumadin)FDA LinkGeneric 04/2019 - 05/2012
13	CreatinineIBA 12/2019 - 03/2010
12	SymportersIBA 12/2023 - 11/2017
12	RelaxinIBA 01/2023 - 04/2009
11	Hemoglobins (Hemoglobin)IBA 01/2023 - 02/2007
11	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 06/2004
10	Mineralocorticoid Receptor AntagonistsIBA 10/2023 - 06/2012
10	Testosterone (Sustanon)FDA Link 01/2021 - 01/2003
10	Purinergic P1 Receptor AntagonistsIBA 11/2019 - 01/2010
9	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2007
9	Soluble Guanylyl CyclaseIBA 10/2020 - 03/2013
8	Uric Acid (Urate)IBA 01/2023 - 04/2003
8	NitrogenIBA 01/2022 - 01/2014
7	HepcidinsIBA 01/2023 - 01/2013
7	Interleukin-6 (Interleukin 6)IBA 05/2022 - 03/2013
7	Oxygen (Dioxygen)IBA 01/2022 - 02/2007
7	Hormones (Hormone)IBA 06/2021 - 12/2009
7	Urea (Carbamide)FDA LinkGeneric 01/2017 - 01/2014
7	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 04/2003
7	AndrogensIBA 12/2016 - 01/2009
6	omecamtiv mecarbilIBA 09/2023 - 03/2016
6	AnticoagulantsIBA 11/2022 - 01/2012
6	Insulin (Novolin)FDA Link 11/2022 - 09/2005
6	PotassiumIBA 11/2022 - 06/2012
6	Transferrin Receptors (Transferrin Receptor)IBA 05/2022 - 05/2018
6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 06/2004
6	Atrial Natriuretic Factor (ANF)IBA 09/2016 - 11/2007
5	sacubitril and valsartan sodium hydrate drug combinationIBA 05/2024 - 01/2017
5	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2023 - 11/2014
5	Angiotensin Receptor AntagonistsIBA 11/2022 - 01/2017
5	Lactic Acid (Lactate)FDA LinkGeneric 10/2022 - 01/2018
5	Cardiac MyosinsIBA 01/2022 - 03/2016
5	AlbuminsIBA 06/2021 - 01/2014
5	AdrenomedullinIBA 01/2020 - 05/2010
5	TroponinIBA 01/2019 - 08/2011
5	Adenosine A1 ReceptorIBA 01/2017 - 05/2011
5	Darbepoetin alfa (Aranesp)FDA Link 03/2012 - 02/2007
4	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2016
4	Furosemide (Lasix)FDA LinkGeneric 01/2024 - 05/2014
4	Growth Differentiation Factor 15IBA 01/2022 - 09/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 09/2006
4	ReninIBA 12/2021 - 12/2019

Therapy/Procedure

143	Therapeutics 05/2024 - 06/2004
26	Patient Readmission 03/2024 - 02/2012
16	Length of Stay 01/2023 - 01/2010
14	Drug Therapy (Chemotherapy) 01/2023 - 01/2008
5	Electric Countershock (Cardioversion) 01/2015 - 10/2012
4	Percutaneous Coronary Intervention 01/2023 - 01/2013
4	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 08/2015
4	Heart Transplantation (Grafting, Heart) 11/2021 - 08/2012
4	Critical Care (Surgical Intensive Care) 01/2019 - 10/2008